baber/WOPTO huggingface dataset:
Patent NZ-544697-A (NZ)
Title: Quinolinone derivatives as inhibitors of c-fms kinase
Inventor: WALL MARK J
IPC: C07D409/04
Filed: 2004-07-20
Abstract: Disclosed is a compound of formula (I) or a solvate, hydrate, tautomer or pharmaceutically acceptable salt thereof, wherein R1 is -H; X is O; Y1, Y2, Y3 and Y4 are -C(R4)-; and wherein the rest of the substituents are disclosed within the specification.
Patent NZ-545540-A (NZ)
Title: CBTF sailing yacht main engine drive system
Inventor: ROBINSON CHARLES W
IPC: B63B41/00
Filed: 2005-03-01
Abstract: A sailing yacht 10, comprising a sailing hull, a ballast 12, a ballast-supporting structure 13 that functions as means for supporting the ballast 12 beneath the sailing hull moveably in order to produce a counter-heeling force that can be varied underway by movement of the ballast-supporting structure, a ballast 12 drive system 16 onboard the sailing hull that functions as means for moving the ballast-supporting structure in order to vary the counter-heeling force, a main engine drive system onboard the sailing hull that functions as means for powering the ballast 12 drive system 16, the main engine drive system including a main engine onboard the sailing hull, a hydraulic pump driven by the main engine that pumps hydraulic fluid, and a flow control valve that couples the hydraulic fluid to the ballast 12 drive system 16, fore and aft foils 14 15 such that the fore foil 14 is mounted on the hull for rotation about a fore axis that extends below the hull in a position forward of the ballast 12 and the aft foil 15 is mounted on the hull for rotation about an aft axis that extends below the hull in a position rearward of the ballast 12, the fore and aft foils 14 15 being mounted on the hull to extend downwardly from the hull, and first means for rotating the fore and aft foils 14 15 together clockwise and together counter clockwise for leeway control, wherein the first means is powered by the main engine drive system directly.
Patent NZ-548093-A (NZ)
Title: Use of neisseria meningitidis gene comprising the SEQ ID NO:15 for treating or preventing a condition associated with infection by Neisseria or Gram-negative bacteria
Inventor: LANE JONATHAN DOUGLAS
IPC: A61P31/04
Filed: 2001-08-21
Abstract: The use of a peptide encoding a gene comprising the nucleotide sequence of SEQ ID NO:15 of N. meningitides in the manufacture of a medicament for treating or preventing a condition associated with infection by Neissera or Gram-negative bacteria. Also disclosed is the use of a peptide comprising amino acid sequence of SEQ ID NO:16, an isolated host cell transformed to express a peptide and an antibody raised against a peptide for treating or preventing a condition associated with infection by Neisseria or Gram-negative bacterium.
Patent NZ-549542-A (NZ)
Title: Apparatus and method for moving and copying rights objects between device and portable storage device
Inventor: LEE BYUNG-RAE
IPC: H04N21/8355
Filed: 2005-03-04
Abstract: A method and apparatus for copying or moving a rights object, having right information regarding digital contents, between a device and a portable storage device to copy or move the digital contents there between is provided. According to the method and apparatus, the digital works can be prevented from being copied and moved, and therefore, copyright can be protected. In addition, data loss or unauthorized access can be prevented.
Patent NZ-549673-A (NZ)
Title: Pyrimidine derivatives and methods of treatment related to the use thereof
Inventor: SEKIGUCHI YOSHINORI
IPC: C07D413/14
Filed: 2005-03-29
Abstract: The present disclosure encompasses novel substituted pyrimidine compounds of Formula (I) which act as MCH receptor antagonists, wherein Q is defined by formulae (IIa) and (IIb) and the variables L, Y and R1 are as defined in the specification. Also disclosed are pharmaceutical compositions whose use includes prophylaxis or treatment of improving memory function, sleeping and arousal, anxiety, depression, mood disorders, seizure, obesity, diabetes, appetite and eating disorders, cardiovascular disease, hypertension, dyslipidemia, myocardial infarction, binge eating disorders including bulimia, anorexia, mental disorders including manic depression, schizophrenia, delirium, dementia, stress, cognitive disorders, attention deficit disorder, substance abuse disorders and dyskinesias including Parkinson's disease, epilepsy, and addiction.
Patent NZ-556286-A (NZ)
Title: Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
Inventor: UMANA PABLO
IPC: A61P35/00
Filed: 2006-02-07
Abstract: Disclosed is an isolated polynucleotide comprising a sequence encoding a polypeptide comprising a heavy chain variable region, or a light chain variable region, or a combination thereof that specifically binds human EGFR as part of a humanised anti-EGFR antigen binding molecule or an antigen binding fragment thereof, wherein said heavy chain and light chain variable regions comprise specific sequence identities as defined in the specification.
Patent NZ-567618-A (NZ)
Title: Method and system for adaptive encoding of real-time information in wireless networks
Inventor: TINNAKORNSRISUPHAP PEERAPOL
IPC: H04N19/89
Filed: 2006-10-20
Abstract: A method for real-time information encoding in wireless communications is disclosed. The method includes receiving at an access terminal feedback information associated with data transmission from a wireless access module and encoding real-time information in accordance with the feedback information. The feedback information includes local feedback information available without delay from within the access terminal and end-to-end feedback information transmitted from a second receiving terminal through a wireless communications network.
Patent NZ-571760-A (NZ)
Title: A devise to transfer articles across spiral conveyors mounded on an arm with linear and arcurate movement
Inventor: SPENCER MARK W
IPC: B65G47/52
Filed: 2007-04-20
Abstract: A conveyance device (10) is disclosed. The devise (10) carries a product from one conveyor to another where the conveyors are positioned next to each other in a spiral configuration. The conveyance device (10) includes a first path (14) that carries the product in a first direction, a second path (18) to carry the product (12) in a second direction. A transfer assembly (22) is positioned adjacent to a portion of the first path (14) to facilitate transfer of the product from the first path (14) to the second path (18). The conveyance device (10) also includes a guide system (110) that moves the transfer assembly (22) along the first path. The guide system (110) includes a base (114) positioned near the first path and second paths and an arm (122) coupled to the base (114) that extends above a portion of the first path and a portion of the second path. The transfer assembly moves along the arm and along an arcuate path with respect to the base that conforms to the path of the conveyors.
Patent NZ-583929-A (NZ)
Title: Headgear for delivering gas under poitive pressure characterised by a laminated conduit which passes on either side of a patients head
Inventor: KWOK PHILIP RODNEY
IPC: A61M16/08
Filed: 2005-04-15
Abstract: Headgear for delivering a supply of gas under a positive pressure to a patient. The headgear includes a connector adapted to be attached to the supply of gas and a pair of side portions adapted to extend along opposite sides of the patient's head. Each of the side portions define a laminated conduit having a first conduit end attached to the connector and a second conduit end adapted to be positioned adjacent the patient's nose. Each conduit extends from the nose to the top of the patient's head, passing between the eyes and ears of the patient.
Patent NZ-583972-A (NZ)
Title: Bra washing device with a shell having two pivotably attached portions closed by a latch
Inventor: PHAN KIEU THI-BICH
IPC: D06C15/00
Filed: 2008-09-16
Abstract: Disclosed is a washing device (100) including a shell (102) and insert. The Shell (102) includes upper shell half (106) and lower shell half (108). The upper shell half (106) and lower shell half (108) are pivotally connected at a hinge (109). The shell (102) may be opened by swinging upper shell half (106) away from lower shell half (108). The insert may be removed from the shell (102) when shell (102) is open. The shell (102) includes latch mechanism (110) which can hold the shell (102) in a closed position.
Patent NZ-587512-A (NZ)
Title: Identification of antigen- or ligand-specific binding proteins
Inventor: GRAWUNDER ULF
IPC: C12N15/867
Filed: 2009-03-04
Abstract: Discloses a method for the isolation and identification of a nucleotide sequence encoding a full-length antibody heavy chain or light chain polypeptide specific for a desired antigen, comprising the steps of: i. transducing a first library of replication incompetent retroviral expression constructs encoding a number of full-length antibody heavy chain or light chain polypeptides into a population of vertebrate host cells such that a first library is generated ii. transducing a second library encoding a number of full-length antibody heavy chain or light chain polypeptides as per (i) so a second library is generated iii. expressing the first expression constructs in the library of transduced cells such that full-length antibodies are expressed on the surface of the transduced cells iv. isolating and identifying at least one nucleotide sequence encoding a full-length antigen specific antibody from the transduced cells; wherein if the vertebrate host cell is a human cell it is located ex vivo
Patent NZ-590889-A (NZ)
Title: Tansgenic plants comprising a senescence specific promoter operably linked to a coding sequence encoding a polypeptide having threonine insensitive aspartate kinase activity
Inventor: JONES LOUISE
IPC: C12N9/12
Filed: 2009-08-14
Abstract: Disclosed is a genetic construct comprising a senescence specific promoter operably linked to a coding sequence encoding a polypeptide having threonine insensitive aspartate kinase activity.
Patent NZ-591688-A (NZ)
Title: Dosage form comprising time-pulsatile release beads
Inventor: VENKATESH GOPI
IPC: A61K9/16
Filed: 2006-05-01
Abstract: Disclosed is a pharmaceutical composition comprising one or more populations of timed, pulsatile release beads, wherein at least one population of time-pulsatile release beads comprises: (a) a core particle comprising a basic active pharmaceutical ingredient or a pharmaceutically acceptable salt thereof, wherein said core particle comprises: (i) an inert particle coated with said basic active pharmaceutical ingredient and optionally a polymeric binder, wherein said polymeric binder is selected from the group consisting of polyvinylpyrrolidone, methylcellulose, hydroxypropylcellulose, hydroxypropyl methylcellulose, corn starch, pregelatinized starch, and mixtures thereof; or (ii) a pellet, mini- or micro-tablet, microgranule, or granular particle containing said basic active pharmaceutical ingredient; (b) an inner barrier coating comprising a water-insoluble polymer in combination with a water-soluble/pore-forming polymer, wherein said water-insoluble polymer is selected from the group consisting of ethylcellulose, cellulose acetate, cellulose acetate butyrate, polyvinyl acetate, methylmethacrylate ester polymers, neutral copolymers based on ethylacrylate and methylmethacrylate, copolymers of acrylic and methacrylic acid esters, and mixtures thereof, and wherein said water-soluble/pore-forming polymer is selected from the group consisting of polyvinylpyrrolidone, methylcellulose, hydroxypropylcellulose, hydroxypropyl ethylcellulose, polyethylene glycol, and mixtures thereof; and(c) an outer lag-time coating comprising a water-insoluble polymer in combination with an enteric polymer, wherein said enteric polymer is selected from the group consisting of cellulose acetate phthalate, hydroxypropyl methylcellulose phthalate, hydroxypropyl methylcellulose succinate, polyvinyl acetate phthalate, pH-sensitive methacrylic acid-methylmethacrylate copolymers, shellac, derivatives thereof, and mixtures thereof; wherein the population of timed, pulsatile release beads provides a lag time of at least 6 hours before onset of drug release.
Patent NZ-592517-A (NZ)
Title: Supercharger system for motorized vehicles and related transportation
Inventor: SIMONS ROBERT
IPC: F01C11/00
Filed: 2009-11-03
Abstract: 592517 A supercharger system (100) having a front end (110), a rear end (120), an inlet (130) and an outlet, the system contained within a housing. The supercharger system includes an integrated bypass valve (160), a rotor assembly (140), and a plurality of intake runners (150) having an interlaced cross-runner pattern. The supercharger system has a front drive, front inlet configuration and an inverted orientation.
Patent NZ-593289-A (NZ)
Title: Anti-neuropilin-1 antibodies for treating angiogenesis
Inventor: WATTS RYAN J
IPC: A61K39/395
Filed: 2006-11-08
Abstract: Disclosed is an anti-neuropilin-1 (NRP1) antibody, and pharmaceutical composition comprising said antibody, capable of inhibiting NRP1's interaction with semaphoring comprising a light chain variable domain. Further disclosed is a polynucleotide encoding said antibody, a vector comprising said polynucleotide, and an isolated host cell comprising said vector. Also claimed is a method of detecting NRP1 protein in a sample, and the use of said antibody in the manufacture of a medicament for the treatment or prevention of a disorder associated with pathological angiogenesis, such as cancer.
Patent NZ-596974-A (NZ)
Title: Production of glutaric acid and derivatives from carbohydrate-containing materials
Inventor: MURPHY VINCENT J
IPC: C07C29/147
Filed: 2010-06-11
Abstract: 596974 Disclosed herein are processes for the chemocatalytic conversion of a pentose source to a glutaric acid product of formula II, wherein R1 is defined in the specification. The process comprises reacting a C5-backbone substrate of formula I and hydrogen gas in the presence of a hydrodeoxygenation catalyst and a halogen source. In one embodiment the hydrodeoxygenation catalyst comprises a first metal selected from Ru, Rh, Pd, Pt, and combinations thereof and a second metal selected from Mo, Ru, Rh, Pd, Ir, Pt, and Au. Also disclosed are processes comprising the catalytic oxidation of pentose to pentaric acid and catalytic hydrodeoxygenation of pentaric acid or derivatives thereof to a glutaric acid product.
Patent NZ-599684-A (NZ)
Title: Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
Inventor: SIESEL DAVID
IPC: C07D213/73
Filed: 2008-12-04
Abstract: 599684 Disclosed is a process for preparing a compound of formula 6a comprising the steps of cross coupling compounds 2a and 3a in a biphasic mixture comprising water, a first organic solvent, a first base, and a transition metal catalyst to produce compound 4a; oxidizing compound 4a to produce compound 5a and adding an amine group to the 6 position of the pyridyl moiety to produce compound 6a. An example of a compound 6a is tert-butyl-3-(6-amino-3-methylpyridin-2-yl)benzoate. An example of a compound of 5a is 2-(3-(tert-butoxycarbonyl)phenyl)-3-methylpyridine-1-oxide. An example of a compound of 4a is tert-butyl-3-(3-methylpyridin-2-yl)benzoate. An example of a compound of 3a is 3-(t-Butoxycarbonyl)phenylboronic acid. An example of a compound of 2a is 2-Bromo-3-methylpyridine.
Patent NZ-604386-A (NZ)
Title: Oval-neck bottle
Inventor: REISIG KARL A
IPC: B65D1/02
Filed: 2011-06-13
Abstract: 604386 Disclosed is a bottle of one-piece construction which has a neck of oval cross section. The bottle includes a body (22) having a shoulder (28), and a neck finish (24). The neck extends from the shoulder to the neck finish. The shoulder and neck finish each have circular cross sections around a central axis (29) of the bottle. A major portion of the neck has an oval cross section around the axis which blends smoothly into the circular cross sections of the shoulder and neck finish. The oval cross section is generally elliptical, having outwardly convex end portions (see 30 & 32, figure 10) and outwardly convex side portions (see 34 & 36, figure 10) extending between the end portions. The neck has a substantially uniform wall thickness. The oval cross section of the major portion of the neck advantageously allows rapid flow of product from the bottle with reduced glugging, and allows fruit, such as slices of lemon or lime, to reside in the bottle neck without restricting product flow.
Patent NZ-604479-A (NZ)
Title: Production of dha and other lc-pufas in plants
Inventor: BEVAN SCOTT
IPC: C12N15/87
Filed: 2011-05-17
Abstract: Disclosed is a genetically modified Brassica plant, descendant, cell, tissue, seed or part thereof, comprising: (i) a nucleic acid sequence that is at least 80% identical to the nucleic acid sequence of SEQ ID NO:6, encoding a polyunsaturated fatty acid (PUFA) synthase that produces at least one PUFA; and (ii) a nucleic acid sequence encoding a phosphopantetheinyl transferase (PPTase) that transfers a phosphopantetheinyl cofactor to a PUFA synthase ACP domain. Also disclosed is an isolated nucleic acid molecule comprising the nucleic acid sequence of SEQ ID NO:6; wherein the sequence is as disclosed in the specification.
Patent NZ-609842-A (NZ)
Title: Housing for encasing an electronic device
Inventor: RAYNER GARY
IPC: B65D85/00
Filed: 2011-10-12
Abstract: A waterproof housing for protecting an electronic device such as a smart phone is disclosed. The housing comprises a top member (2) comprising a rigid frame (20a) that defines a cavity into which the electronic device may be fitted and a membrane (25) mated on a top ridge of the rigid frame (20a). A bottom member (3) is configured to be removably coupled to the top member (2). A channel (10) in the perimeter of the bottom member (3) receives a bottom ridge of the rigid frame (20a). The channel includes a gasket (15) to compress against the bottom ridge of the rigid frame when the top member (2) and the bottom member (3) are coupled together to seal the housing. A clasping mechanism maintains the top member (2) and the bottom member (3) coupled together and comprises a groove in a side of the channel and a lip (27) extending from the bottom ridge of the rigid frame (20a) which engages in the groove. The membrane (2) may allow touch-sensitive input to the electronic device and the housing may further include a plurality of sealed buttons, sealable apertures or transparent windows to accommodate features of the electronic device.
Patent NZ-610074-A (NZ)
Title: Processing biomass
Inventor: MEDOFF MARSHALL
IPC: C08J11/04
Filed: 2009-10-26
Abstract: The disclosure relates to a method of processing a carbohydrate-containing material, the method comprising: converting an irradiated material to a product using an enzyme and/or microorganism, the irradiated material having been produced by exposing a combination formed by combining a cellulosic or lignocellulosic material with an inorganic material comprising a ceramic, wherein said inorganic material does not comprise a metal or metal alloy, and exposing the combination to accelerated particles, wherein the combination is provided by dry blending or co-comminuting the cellulosic or lignocellulosic material and inorganic material; wherein the ceramic is selected from the group consisting of oxides, carbides, borides, nitrides, silicides and kaolins, , wherein the inorganic material may further comprise a refractory material selected from the group consisting of zircon, fireclay, silica, alumina, chromite, silicon carbide, carbon, mulitite, dolomite and magnesite, and , wherein the inorganic material may further comprise water that is capable of leaving the inorganic material at elevated temperatures.
Patent NZ-617346-A (NZ)
Title: L-proline and citric acid co-crystals of (2s,3r,4r,5s,6r )-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol
Inventor: COLLIER EDWIN A
IPC: C07H7/04
Filed: 2012-05-09
Abstract: Provided herein is L-proline and citric acid co-crystals of (2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4- methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol (I-X), pharmaceutical compositions containing said co-crystals and their use in the treatment glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X.
Patent NZ-617719-A (NZ)
Title: Multi-compartment tray-less package with a rigid frame
Inventor: CHRYSANTHIDIS CHRISTOFOROS
IPC: B65D85/76
Filed: 2013-11-13
Abstract: 617719 Disclosed is a tray-less compartment package (1A) of individually sealed compartments and a method for manufacturing the multi-compartment package (1A). Multi-compartment packages are advantageous as each portion of a product is sealed individually and thus reduces odour migration and taste cross contamination. The tray-less compartment package (1A) comprises two outermost films (5); at least two products (2) in stack; at least one internal film (6) and a peripheral circumferential continuous seal. The at least one internal film (6) is interposed between the two products (2) in stack. The peripheral circumferential continuous seal seals the films (5, 6) in stack together and delimits at least two sealed compartments in stack. Each compartment encloses at least a product (2) of said at least two products (2) in stack. The films (5, 6) comprise a crystallisable polymer. The crystallisable polymer is at least partially crystallized in correspondence of the sealing area thus providing a peripheral circumferential continuous rigid frame (3).
Patent NZ-619689-A (NZ)
Title: Method of manufacturing confectionery shells
Inventor: GUSTAV THORSTEN
IPC: A23G3/54
Filed: 2012-07-02
Abstract: A method of producing a confectionery shell and a shell produced by such a process. The process comprises depositing a first edible liquid (1) into a mould (2), pressing the liquid against the walls of the mould by a stamp (3), and removing the stamp from the mould. The stamp has a surface temperature below the solidification temperature of the first edible liquid so as to shape and at least partially solidify the first edible liquid in the mould cavity. The stamp is used to shape a second edible liquid after shaping the first edible liquid. The second edible liquid may be applied on top of the first edible liquid to form a multilayer shell, or may be applied in a second mould cavity. The surface temperature of the mould being below the solidification temperature of the second edible liquid. The distance the stamp is pressed into the mould cavity when processing the second liquid is different to the distance the stamp is pressed into the mould cavity when processing the first liquid. The method additionally includes the step of removing excess material which is squeezed from the mould by the stamp using scrapers.
Patent NZ-702485-A (NZ)
Title: The use of inhibitors of bruton’s tyrosine kinase (btk)
Inventor: LOURY DAVID J
IPC: C07D487/04
Filed: 2011-06-03
Abstract: Disclosed is the use of the inhibitor of Bruton’s tyrosine kinase (Btk) (R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one / ibrutinib / PCI-32765 in the preparation of a medicament for treating Waldenstrom’s macroglobulinemia in an individual wherein, the medicament comprises from 420mg to 840mg of said inhibitor, the medicament is formulated for oral administration, and said individual has already received at least one prior therapy for Waldenstrom’s macroglobulinemia.